Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × B-cell Malignancies × itacitinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myeloproliferative Disorders 3 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 B-cell Malignancies 1

Interventions

zanubrutinib 1 tislelizumab 1 itacitinib 1 INCB039110 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01905813 2025-12-19

Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies

Incyte Corporation

Phase 1 Active not recruiting

B-cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡